Rational design of the linkers in targeting chimeras

Yiping Duan, Michelle Y. Cai, Jinyi Xu and Quanyin Hu

Chem. Sci., 2025, 16, 17595
DOI: 10.1039/D5SC04859A

Innovative, combinatorial and high-throughput approaches to degrader synthesis

Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, Glenn A. Burley, David J. Battersby and Afjal H. Miah

Chem. Soc. Rev., 2024, 53, 4838
DOI: 10.1039/D3CS01127E

Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine

Sijun Pan, Aixiang Ding, Yisi Li, Yaxin Sun, Yueqin Zhan, Zhenkun Ye, Ning Song, Bo Peng, Lin Li, Wei Huang and Huilin Shao

Chem. Soc. Rev., 2023, 52, 5706
DOI: 10.1039/D3CS00056G

Glycomimetics for the inhibition and modulation of lectins

Steffen Leusmann, Petra Ménová, Elena Shanin, Alexander Titz and Christoph Rademacher

Chem. Soc. Rev., 2023, 52, 3663
DOI: 10.1039/D2CS00954D

Targeting mitochondrial degradation by chimeric autophagy-tethering compounds

Zhenqi Liu, Geng Qin, Jie Yang, Wenjie Wang, Wenting Zhang, Boxun Lu, Jinsong Ren and Xiaogang Qu

Chem. Sci., 2023, 14, 11192
DOI: 10.1039/D3SC03600F

Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways

Mohammad Maqusood Alam, Sobia Wasim and Sang-Yoon Lee

IJMS, 2025, 26, 5582
DOI: 10.3390/ijms26125582

Nanotechnology enabled proximity-induced protein degradation from multiscale bottlenecks to precision therapeutics

Xiaoning Pan, Huiyuan Jin, Jian Song, Peng Wang, Huan Min, Guangjun Nie and Yingqiu Qi

Advanced Drug Delivery Reviews, 2026, 234, 115880
DOI: 10.1016/j.addr.2026.115880

Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera

Xin Chang, Xinyu Qiu, Xiaoning Tong, Shaoju Gan, Weicheng Yi, Sitao Xie, Xiangsheng Liu, Chao Zuo and Weihong Tan

Advanced Science, 2025, 12
DOI: 10.1002/advs.202501222

From Epigenetic Regulation to Protein Degradation: Emerging Strategies for Anti-Infective Drug Discovery

Andressa Francielli Bonjorno, Diogo Boreski, Ana Luísa Rodriguez Gini, Pamela Souza Tada da Cunha, Jhonnathan Alves Moura, Chung Man Chin, Cauê Benito Scarim and Jean Leandro Dos Santos

IJMS, 2026, 27, 3977
DOI: 10.3390/ijms27093977

P53 upregulation by USP7-engaging molecular glues

Zhaoyang Li, Ziying Wang, Chao Zhong, Hang Zhang, Rui Liu, Ping An, Zhiqiang Ma, Junmei Lu, Chengfang Pan, Zhaolin Zhang, Zhiyuan Cao, Jianyi Hu, Dong Xing, Yiyan Fei, Yu Ding and Boxun Lu

Science Bulletin, 2024, 69, 1936
DOI: 10.1016/j.scib.2024.04.017

Analysis of Fluid Replacement in Two Fluidic Chambers for Oblique–Incidence Reflectivity Difference (OI-RD) Biosensor

Haofeng Li, Mengjing Xu, Xiaohan Mai, Hang Zhang, Xiangdong Zhu, Lan Mi, Jiong Ma and Yiyan Fei

Sensors, 2024, 24, 2000
DOI: 10.3390/s24062000

Autophagy‐Mediated Targeted Protein Degradation

Jinning Shao, Shangzhi Xie, Shurui Hong and Linghui Qian

ChemMedChem, 2025, 20
DOI: 10.1002/cmdc.202400866

Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview

Xu Liu, Yang Cheng, Yao Mu, Zhaohan Zhang, Dan Tian, Yunpeng Liu, Xuejun Hu and Ti Wen

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1328145

Bioorthogonally Activatable Autophagy-Tethering Compounds for Aptamer-Guided Mitochondrial Degradation

Mengmeng Liu, Zhenqi Liu, Geng Qin, Jinsong Ren and Xiaogang Qu

Nano Lett., 2023, 23, 4965
DOI: 10.1021/acs.nanolett.3c00798

Development of a p62 biodegrader for autophagy targeted degradation

Zacharias Thiel, David Marcellin, Carole Manneville, Benedikt Goretzki, Luca Egger, Rob Maher, Noémie Siccardi, Laura Torres, Alexandra Probst, Catrin S. Müller, Nathalie George, Markus Vogel, Sabine Sinterhauf, Alexandra Lavoisier, Ji-Young Choi, Laurianne Forcellino, Alexandro Landshammer, Patrick Hauck, Celine Be, Frédéric Villard, Sascha Gutmann, Marc Meyer, Felix Freuler, Alexandra Hinniger, César Fernández, Suzanne Chau, Maude Patoor, Gilles Sansig, Gabriel Mitchell and Beat Nyfeler

Nat Commun, 2025, 16
DOI: 10.1038/s41467-025-65868-9

Phototriggered LYTAC: Photoactive Bispecific Aptamer Chimera Enhances Targeted Degradation of Membrane Protein through Regulating Cell Autophagy

Rongjun Zhang, Changjie Yang, Xiaobo Gao, Zhenyang He, Ding-Kun Ji and Weihong Tan

J. Am. Chem. Soc., 2025, 147, 20989
DOI: 10.1021/jacs.5c05456

Recent breakthroughs in innovative elements, multidimensional enhancements, derived technologies, and novel applications of PROTACs

Si-Han Zhang, Na Zeng, Jin-Zhou Xu, Chen-Qian Liu, Meng-Yao Xu, Jian-Xuan Sun, Ye An, Xing-Yu Zhong, Lin-Tao Miao, Shao-Gang Wang and Qi-Dong Xia

Biomedicine & Pharmacotherapy, 2024, 180, 117584
DOI: 10.1016/j.biopha.2024.117584

Surface engineering of nanoparticles for precision medicine

Jiaxi Zheng, Yuji Sun, Youqing Shen and Zhuxian Zhou

Precision Medicine and Engineering, 2025, 2, 100037
DOI: 10.1016/j.preme.2025.100037

Quantitative analysis of ternary complex kinetics by a surface immobilization method

Xiaohan Mai, Yang Luo, Ruoxin Fang, Haina Zhang, Lan Mi, Jiong Ma, Xiangdong Zhu, Yu Ding and Yiyan Fei

Biochemical and Biophysical Research Communications, 2026, 811, 153535
DOI: 10.1016/j.bbrc.2026.153535

Advancing Design Strategy of PROTACs for Cancer Therapy

Hang Luo, Yuan Tian, Razack Abdullah, Baoting Zhang, Yuan Ma and Ge Zhang

MedComm, 2025, 6
DOI: 10.1002/mco2.70258

The role of redox-mediated lysosomal dysfunction and therapeutic strategies

Xiaomeng He, Xuening Li, Wei Tian, Chenyu Li, Pengfei Li, Jingyuan Zhao, Shilei Yang and Shuai Li

Biomedicine & Pharmacotherapy, 2023, 165, 115121
DOI: 10.1016/j.biopha.2023.115121

Autophagy mediated targeting degradation, a promising strategy in drug development

Jiantao Zhang, Xiangyi Pan, Wenshu Ji and Jinming Zhou

Bioorganic Chemistry, 2024, 149, 107466
DOI: 10.1016/j.bioorg.2024.107466

A pH-Sensitive NIR Fluorescent Probe as a Protagonist in the Discovery of New LC3 Ligands Facilitating the Construction of ATTECs

Xiaohao Xie, Xinru Zheng, Ziwen Zhang, Kehuan Wu, Lixin Sun, Hongyu Wu, Yongxing Xue, Shaozong Ma, Chunchang Zhao and Xianfeng Gu

Anal. Chem., 2025, 97, 10755
DOI: 10.1021/acs.analchem.5c00941

KIF20A inhibits TRIM21-dependent ubiquitination of DHX9 to boost SOX2 stability, enhancing OSCC stemness and ferroptosis resistance

Ziyun Zhang, Yi Li, Jingjiang Hu, Xingjie Tang, Zhanpeng Li, Xiaoyan Sun, Dade Feng, Yixin Yao, Chao Mao, Yongguang Tao, Li Xie, Huaiqing Luo, Yufei Li, Xing Yu, Xiaoning Peng, Li Cong and Yiqun Jiang

Cell Death Dis, 2026, 17
DOI: 10.1038/s41419-026-08467-w

Targeting the autophagy-lysosomal pathway in Huntington disease: a pharmacological perspective

Junsheng Yang and Chaoyue Zhang

Front. Aging Neurosci., 2023, 15
DOI: 10.3389/fnagi.2023.1175598

Autophagy modulation in cancer therapy: Challenges coexist with opportunities

Yongya Wu, Aoxue Wang, Guotai Feng, Xiaoli Pan, Wen Shuai, Panpan Yang, Jing Zhang, Liang Ouyang, Yi Luo and Guan Wang

European Journal of Medicinal Chemistry, 2024, 276, 116688
DOI: 10.1016/j.ejmech.2024.116688

Journey of PROTAC: From Bench to Clinical Trial and Beyond

Kyli Berkley, Julian Zalejski, Nidhi Sharma and Ashutosh Sharma

Biochemistry, 2025, 64, 563
DOI: 10.1021/acs.biochem.4c00577

Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs

Fei Teng, Jing Liu, Tongtong Cui, Xiangtian Tan, Kailun Liu, Zongren Hou, Li Zhou, Yuanzhi Xie, Rongqi Li, Da Li, Bojin Li, Dongmei Wang, Qi Zhou, Baoyang Hu and Wei Li

Cell, 2026, 189, 1923
DOI: 10.1016/j.cell.2026.01.034

Supramolecular Host–Guest Assemblies for Tunable and Modular Lysosome‐Targeting Protein Degradation

Xuetao Chen, Tingting Wu, Yali Chen, Huidan Wu, Wenjing Kang, Nan Wang, Qidong You, Xiaoke Guo and Zhengyu Jiang

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202506618

Inducing potent ferroptosis in cancer cells by manipulation of ferritinophagy with a ferritin-targeted ATTEC

Zilin Song, Yan Gao, Xue Zou, Zheng Wang, Shihan Zhang, Jiru Shen, Tingyu Yang, Xiuli Zhao, Dawei Chen and Mingxi Qiao

Journal of Controlled Release, 2026, 389, 114450
DOI: 10.1016/j.jconrel.2025.114450

ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells

Zhiyan Wang, Tingting Xu, Yiying Che, Jun-An Ma, Runqi Jin, Boao Mao, Xinru Lai, Kunrong Mei, Hongxia Zhao and Zhiguang Yuchi

European Journal of Medicinal Chemistry, 2026, 303, 118430
DOI: 10.1016/j.ejmech.2025.118430

DSS1 inhibits autophagy to activate epithelial-mesenchymal transition in a pro-metastatic niche of renal cell carcinoma

Xiaoyu Chen, Qingyuan Liu, Jingxian Wu, Pengfei Zhou, Mingming Zhao and Jing Song

Nat Commun, 2025, 16
DOI: 10.1038/s41467-025-62135-9

TPDdb: the comprehensive database of targeted protein degrader

Xinran Qin, Yinpeng Zhang, Yajunzi Wang, Yintao Zhang, Jiachen Jing, Yuyuan Zhang, Gaoxiang Xu, Haoping Teng, Tianjun Wang, Lei Fu, Ying Zhou, Xin Liu and Feng Zhu

Nucleic Acids Research, 2026, 54, D1683
DOI: 10.1093/nar/gkaf996

Novel insight into PINK1/parkin-associated autophagy implicated in Parkinson disease

Judith Stegmüller

Translational Neuroscience, 2026, 17
DOI: 10.1515/tnsci-2025-0386

TAC‐tics for Leveraging Proximity Biology in Drug Discovery

Dhanusha A. Nalawansha, Kyle Mangano, Willem den Besten and Patrick Ryan Potts

ChemBioChem, 2024, 25
DOI: 10.1002/cbic.202300712

Targeting selective autophagy in CNS disorders by small-molecule compounds

Yanrong Zheng, Zhuchen Zhou, Mengting Liu and Zhong Chen

Pharmacology & Therapeutics, 2024, 263, 108729
DOI: 10.1016/j.pharmthera.2024.108729

Insights into RAS-driven melanoma and its therapeutic implications

Eftychia Chatziioannou, Konstantinos Lallas, Tobias Sinnberg, Heike Niessner, Alexander J. Stratigos, Lukas Flatz and Teresa Amaral

Cancer Treatment Reviews, 2026, 143, 103090
DOI: 10.1016/j.ctrv.2026.103090

New strategies to enhance the efficiency and precision of drug discovery

Qi An, Liang Huang, Chuan Wang, Dongmei Wang and Yalan Tu

Front. Pharmacol., 2025, 16
DOI: 10.3389/fphar.2025.1550158

HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications

Emma Cuttini, Camilla Goi, Ester Pellarin, Riccardo Vida and Claudio Brancolini

Front. Mol. Biosci., 2023, 10
DOI: 10.3389/fmolb.2023.1116660

Multivalent DNA lysosome-targeting chimaera for targeted protein degradation and inhibition of c-Met signaling pathways

Xinhuan Chen, Mengmeng Ji, Xue Bai, Tianlu Zhang, Xiao Li, Yuanrui Wang, Wei Li, Hongmei Geng, Xin Li, Jing Lu, Jinlu Tang, Kangdong Liu, Baoyin Yuan and Zhaohui Li

Chemical Engineering Journal, 2025, 511, 161974
DOI: 10.1016/j.cej.2025.161974

Verteporfin Inhibits Severe Fever with Thrombocytopenia Syndrome Virus Infection via Inducing the Degradation of the Viral Gn Protein

Bingan Wu, Chenyang Yu, Yuxiang Lin, Ping Zhao, Zhongtian Qi and Xijing Qian

Pharmaceutics, 2025, 17, 434
DOI: 10.3390/pharmaceutics17040434

Targeting autophagy via mitochondrial uncoupling: Discovery of novel serratin derivative as a potential therapeutic for Parkinson's disease

Alexander Yu Rudenko, Ekaterina А. Guseva, Ratislav M. Ozhiganov, Boris P. Myasnikov, Maria V. Belopolskaya, Olga V. Fadeeva, Elena О. Morgun, Olga A. Averina, Elena A. Tukhovskaya, Gulsara A. Slashcheva, Igor A. Dyachenko, Elena I. Marusich, Mariia Mokhina, Rose-Lys Zaranaina, Yuriy A. Ikhalaynen, Igor A. Rodin, Ljudmila S. Khailova, Yuri N. Antonenko, Vladimir I. Polshakov, Maxim L. Lovat, Viktor G. Kartsev, Arkady N. Murashev and Petr V. Sergiev

Biochimie, 2026, 240, 125
DOI: 10.1016/j.biochi.2025.10.011

Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)

Shilong Zhang, Yi Guo, Shenjie Zhang, Zhi Wang, Yewei Zhang and Shi Zuo

Oncol Rep, 2023, 50
DOI: 10.3892/or.2023.8613

Advances in Peptide-Based Chimeric Strategies for Targeted Protein Degradation

Yixuan Wang, Jingyuan Zhao, Hong Yuan and Shuai Li

J. Med. Chem., 2025, 68, 25708
DOI: 10.1021/acs.jmedchem.5c02379

Assembly/disassembly-based targeting protein degradation systems for cancer therapy

Hongzhe Yan, Xiaoyang Liu, Ying Xu, Gaolin Liang and Xiaofeng Wu

EngMedicine, 2026, 3, 100115
DOI: 10.1016/j.engmed.2025.100115

Erasable Fluorescence Imaging Technology Enables Continuous Tracking for Identical Living Cells

Yanan Peng, Qiumei Pu, Liangqing Lu, Qionglin Zhou, Xinxin Xiao, Xiangde Lai, Xuan Zhao, Bin Qiao and Qiang Wu

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202503818

Erasable Fluorescence Imaging Technology Enables Continuous Tracking for Identical Living Cells

Yanan Peng, Qiumei Pu, Liangqing Lu, Qionglin Zhou, Xinxin Xiao, Xiangde Lai, Xuan Zhao, Bin Qiao and Qiang Wu

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202503818

Peptide-Mediated Small Molecule Lysosome-Targeting Chimeras for Targeted Degradation of Membrane and Intracellular Proteins

Shuqiang Chen, Wei Wang, Zhipeng Chen, Ruyan Li, Zhe Wu, Guoqiang Dong and Chunquan Sheng

J. Med. Chem., 2024, 67, 15807
DOI: 10.1021/acs.jmedchem.4c01449

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1

Fabio Arias, Sumati Rohilla, Yudibeth Sixto-López, Koral S. E. Richard, Sandeep Das, Sumit K. Anand, Pilar Maria Luque-Navarro, Guillermo Bañuelos-Sanchez, Juan Luis Pacheco-García, Reethika Gade, M. Peyton McKinney, Dhananjay Kumar, Jemiah Maxie, W. Rylan Corr, Nilesh Pandey, Harpreet Kaur, Jibin Ding, Lin Tan, Elisha Scott, Hyung Nam, Eyal Gottlieb, A. Wayne Orr, Nirav Dhanesha, Arif Yurdagul, Angel L. Pey, Francisco Franco-Montalbán, José A. Gómez Vidal, Oren Rom and Mónica Díaz-Gavilán

J. Med. Chem., 2026, 69, 2258
DOI: 10.1021/acs.jmedchem.5c02055

Targeted protein degradation in cancers: Orthodox PROTACs and beyond

Jin Li, Xinxin Chen, Aiping Lu and Chao Liang

The Innovation, 2023, 4, 100413
DOI: 10.1016/j.xinn.2023.100413

Unleashing the Power of Covalent Drugs for Protein Degradation

Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, Liang Shen, Hong‐Min Liu, Ying Liu, Yi‐Chao Zheng and Xing‐Jie Dai

Medicinal Research Reviews, 2025, 45, 1045
DOI: 10.1002/med.22101

Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy

Kai Yin, Ziwen Zhang, Yanqing Mo, Hongyu Wu, Zhonglian Cao, Yongxing Xue, Mingrunlin Wang, Wei Guo, Li Feng, Chunchang Zhao and Xianfeng Gu

European Journal of Medicinal Chemistry, 2024, 275, 116581
DOI: 10.1016/j.ejmech.2024.116581

Nucleoside-ATTEC Conjugates for Targeting Inhibition of HIV Replication and Infection

Xiaofeng Liao, Kaifu Zhang, Chu Wang, Mengmeng Liu, Jinsong Ren and Xiaogang Qu

J. Med. Chem., 2026, 69, 8807
DOI: 10.1021/acs.jmedchem.5c02422

Targeted protein degradation: expanding the technology to facilitate the clearance of neurotoxic proteins in neurodegenerative diseases

Xin Wang, Wen Shuai, Panpan Yang, Yinyang Liu, Yiwen Zhang and Guan Wang

Ageing Research Reviews, 2024, 102, 102584
DOI: 10.1016/j.arr.2024.102584

Detection speed optimization of the OI-RD microscope for ultra-high throughput screening

Hang Zhang, Mengjing Xu, Haofeng Li, Xiaohan Mai, Jiawei Sun, Lan Mi, Jiong Ma, Xiangdong Zhu and Yiyan Fei

Biomed. Opt. Express, 2023, 14, 2386
DOI: 10.1364/BOE.487563

Recent advances in targeted protein degraders as potential therapeutic agents

Na Yang, Bo Kong, Zhaohong Zhu, Fei Huang, Liliang Zhang, Tao Lu, Yadong Chen, Yanmin Zhang and Yulei Jiang

Mol Divers, 2024, 28, 309
DOI: 10.1007/s11030-023-10606-w

Degraders upgraded: the rise of PROTACs in hematological malignancies

Joshua M. L. Casan and John F. Seymour

Blood, 2024, 143, 1218
DOI: 10.1182/blood.2023022993

Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations

Yanping Zeng, Jian Xiao, Li Shi, Yangsha Li, Yuanxin Xu, Jiayun Zhou, Xiao Dong, Haiyang Hou, Chao Zhong, Gang Cheng, Yi Chen, Naixia Zhang, Yanfen Fang and Youhong Hu

European Journal of Medicinal Chemistry, 2025, 287, 117293
DOI: 10.1016/j.ejmech.2025.117293

Extracellular vesicles in cancer´s communication: messages we can read and how to answer

Alena Semeradtova, Michaela Liegertova, Regina Herma, Magdalena Capkova, Chiara Brignole and Genny Del Zotto

Mol Cancer, 2025, 24
DOI: 10.1186/s12943-025-02282-1

Autophagy degradation: a promising dimension in drug discovery for neurodegenerative diseases

Shuai-Jiang Liu, Chenxi Cai, Hong-Ping Zhu, Xiang Li and Bo Han

Future Medicinal Chemistry, 2024, 16, 2563
DOI: 10.1080/17568919.2024.2431477

A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation

Yangyang Huang, Xujiao Zhou, Yirou Zhang, Miao Xie, Fujun Wang, Jingcan Qin, Han Ye, Hong Zhang, Chuan Zhang and Jiaxu Hong

Advanced Science, 2024, 11
DOI: 10.1002/advs.202306248

Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy

Adele Rivault, Jade Dussart-Gautheret, Rachid Benhida, Anthony R Martin, Patrick Auberger, Arnaud Jacquel and Guillaume Robert

Autophagy, 2026, 22, 881
DOI: 10.1080/15548627.2026.2618626

Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research

Xiang Li, Qian Liu, Xin Xie, Cheng Peng, Qiwen Pang, Bo Liu and Bo Han

J. Med. Chem., 2023, 66, 1700
DOI: 10.1021/acs.jmedchem.2c01712

Diversified design strategies for small-molecule PROTACs: How do we select?

Qing-Song Chen and Jian-Hua Liang

European Journal of Medicinal Chemistry, 2026, 306, 118593
DOI: 10.1016/j.ejmech.2026.118593

Emerging drug design strategies in anti-influenza drug discovery

Chuanfeng Liu, Lide Hu, Guanyu Dong, Ying Zhang, Edeildo Ferreira da Silva-Júnior, Xinyong Liu, Luis Menéndez-Arias and Peng Zhan

Acta Pharmaceutica Sinica B, 2023, 13, 4715
DOI: 10.1016/j.apsb.2023.08.010

Hijacking ERAD for targeted degradation of transmembrane proteins

Haikun Song, Wei Wang, Tingfang Mei, Huiwen Zheng, Keni Ning, Xiaofan Liu, Siulam Cheung, Zhiyuan Cao, Danqi Sheng, Xiaohan Mai, Haoran Zhu, Guankai Guo, Shuaimeng Liu, Rongkai Wei, Qian Wang, Yu Cao, Yu Ding, Yiyan Fei, Rui Liu, Motoyuki Hattori, Chunquan Sheng and Boxun Lu

Cell, 2026, 189, 1768
DOI: 10.1016/j.cell.2026.01.018

Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets

Mayuri P Kannan, Sarojini Sreeraman, Chaitanya S Somala, Raja BS Kushwah, Saravanan K Mani, Vickram Sundaram and Anand Thirunavukarasou

Future Med. Chem., 2023, 15, 867
DOI: 10.4155/fmc-2023-0072

Strategies for targeted protein degradation through lysosomal pathways

Wei Wang, Yuxin Fang and Chunquan Sheng

Advanced Drug Delivery Reviews, 2026, 232, 115837
DOI: 10.1016/j.addr.2026.115837

GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins

Yuxin Fang, Yaojin Zhu, Wei Wang, Zhewei Xia, Shipeng He, Guoqiang Dong and Chunquan Sheng

Acta Pharmaceutica Sinica B, 2025, 15, 2156
DOI: 10.1016/j.apsb.2025.02.037

Molecular mechanisms of autophagy-lysosomal pathway dysfunction in neurodegenerative diseases and therapeutic strategies for lysosomal repair: a review

Weilin Wang and Xianguo Meng

Front. Neurosci., 2026, 20
DOI: 10.3389/fnins.2026.1819002

Enhanced lysosome biogenesis ameliorates neurodegenerative diseases

Wenlong Xue and Yang Li

Aging, 2022, 14, 8582
DOI: 10.18632/aging.204389

Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation

Jiachan Lin, Zirui Chen, Dan Zhang, Nan Zhang, Hongzhong Chen and Dong‐Sheng Guo

Macromol. Rapid Commun., 2025, 46
DOI: 10.1002/marc.202401051

Development of Antibody‐Based Strategies for Targeted Degradation of Membrane and Extracellular Proteins

Huanhuan Sun, Na Li and Xiaoqing Cai

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202500184

Targeting the ATG12–ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation

Emadeldin M. Kamel, Sally Mostafa Khadrawy, Ahmed A. Allam, Noha A. Ahmed, Faris F. Aba Alkhayl and Al Mokhtar Lamsabhi

Pathology - Research and Practice, 2025, 273, 156156
DOI: 10.1016/j.prp.2025.156156

Visual Whole-Process Monitoring Dynamic Phase Separation of Autophagic Lysosomes in Alzheimer’s Disease by a Lysosome-Targeted pH-Activated Fluorescence Probe

Fei Gao, Wanquan Lin, Tingting Zhao, Jinlong Zhang, Dong Pei, Duolong Di, Zhongxiong Fan, Lichao Yang and Jun Hai

Anal. Chem., 2025, 97, 22518
DOI: 10.1021/acs.analchem.5c02994

Receptor-ligand interactions for optimized endocytosis in targeted therapies

Yejin Sung, Youngjin Choi, Eun Sun Kim, Ju Hee Ryu and Ick Chan Kwon

Journal of Controlled Release, 2025, 380, 524
DOI: 10.1016/j.jconrel.2025.01.060

Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors

Qiangfeng Wang, Yumeng Zhu and Junping Pei

Future Medicinal Chemistry, 2024, 16, 1923
DOI: 10.1080/17568919.2024.2389764

Recent advances in degraders engaging lysosomal pathways and related nanomedicine

Runxin Lu, Xiaofeng Ni, Sha Diao, Yong Wu and Lingli Zhang

European Journal of Medicinal Chemistry, 2025, 292, 117701
DOI: 10.1016/j.ejmech.2025.117701

PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age

Jiale Cai, Chen Chen, Jiayue Wang, Xinmeng Zhang, Yuqiu Cui, Qunshan Zhu and Haibo Sun

Front. Oncol., 2025, 15
DOI: 10.3389/fonc.2025.1676414

Induction de proximité et dégradation de cibles thérapeutiques par les nouveaux dégradeurs : quels concepts, quels développements, quel futur ?

Michèle Reboud-Ravaux

Biologie Aujourd’hui, 2024, 218, 41
DOI: 10.1051/jbio/2024007

PROTACs: A novel strategy for cancer drug discovery and development

Xin Han and Yi Sun

MedComm, 2023, 4
DOI: 10.1002/mco2.290

Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases

Yuqi Fu, Jin Zhang, Rui Qin, Yueting Ren, Tingting Zhou, Bo Han and Bo Liu

Pharmacological Reviews, 2025, 77, 100053
DOI: 10.1016/j.pharmr.2025.100053

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery

Yutong Wang, Shiyu Luo, Hongbao Sun, Shuai Huang, Lianhai Shan and Jifa Zhang

Drug Discovery Today, 2025, 30, 104347
DOI: 10.1016/j.drudis.2025.104347

Targeted protein degradation: building a platform for biomolecule clearance

Yu DING and BoXun LU

Sci. Sin.-Vitae, 2026, 56, 924
DOI: 10.1360/SSV-2025-0285

Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases

Wenlong Xue, Jie Zhang and Yang Li

Neural Regeneration Research, 2023, 18, 2370
DOI: 10.4103/1673-5374.371346

Selenium Nanodots (SENDs) as Antioxidants and Antioxidant‐Prodrugs to Rescue Islet β Cells in Type 2 Diabetes Mellitus by Restoring Mitophagy and Alleviating Endoplasmic Reticulum Stress

Qiong Huang, Zerun Liu, Yunrong Yang, Yuqi Yang, Ting Huang, Ying Hong, Jinping Zhang, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Xuejun Gong, Yitian Jiang, Jiang Peng, Yayun Nan and Kelong Ai

Advanced Science, 2023, 10
DOI: 10.1002/advs.202300880

Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects

Shuixia Tan, Da Wang, Yuhua Fu, Huiwen Zheng, Yan Liu and Boxun Lu

Science Bulletin, 2023, 68, 3013
DOI: 10.1016/j.scib.2023.10.021

PROTACS: A technology with a gold rush-like atmosphere

Yu-Wei Wang, Li Lan, Min Wang, Jin-Yang Zhang, Yu-Hui Gao, Lei Shi and Li-Ping Sun

European Journal of Medicinal Chemistry, 2023, 247, 115037
DOI: 10.1016/j.ejmech.2022.115037

Chuhui Huang, Kate S. Harris, Ghizal Siddiqui and Manuela Jörg

ACS Pharmacol. Transl. Sci., 2025, 8, 978
DOI: 10.1021/acsptsci.4c00726

Drosophila as a Promising In Vivo Research Model for the Application and Development of Targeted Protein Inactivation Technologies

Natalia V. Dorogova and Svetlana A. Fedorova

Arch Insect Biochem Physiol, 2025, 118
DOI: 10.1002/arch.70046

Lysosome and related protein degradation technologies

Hongmei Zheng, Gangjian Li, Jingli Min, Xiangwei Xu and Wenhai Huang

Drug Discovery Today, 2023, 28, 103767
DOI: 10.1016/j.drudis.2023.103767

Zwitterionic Sulfadiazine-Based Micelle Achieves Effective Drug Delivery to Glioblastoma by Overcoming Multiple Biological Barriers

Ke Zheng, Xumei Ouyang, Jing Li, Yongbin Cao and Shaojun Peng

J. Am. Chem. Soc., 2025, 147, 34742
DOI: 10.1021/jacs.5c10422

Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential

Rongli Wang, Yi He, Yan Wang, Jing Wang and Hu Ding

IJC Heart & Vasculature, 2025, 58, 101675
DOI: 10.1016/j.ijcha.2025.101675

Autophagosome degraders: a novel therapeutic strategy with broad application potential in human diseases

Wei‑Fang Zuo, Xinyi Huang, Cheng Peng, Bo Han and Qian Zhao

Future Medicinal Chemistry, 2026, 18, 353
DOI: 10.1080/17568919.2025.2605014

Microglial Membrane Camouflaged Nano‐AUTAC to Promote Autophagy‐Mediated β‐Catenin Degradation for Reducing TMZ Resistance in Glioblastoma

Shuai Wu, Ya Wang, Yunfan Li, Minyao Qiu, Yuan Zhong, Maolan Zhang, Haifeng Yang, Jianshu Li and Wei Wu

Adv Funct Materials, 2026, 36
DOI: 10.1002/adfm.202528010

Selective Protein Degradation through Tetrazine Ligation of Genetically Incorporated Unnatural Amino Acids

Jinghao Chen, Gaocan Dai, Shixiang Duan, Yang Huang, Yi‐Lin Wu, Zhiyong Xie and Yu‐Hsuan Tsai

Chemistry An Asian Journal, 2024, 19
DOI: 10.1002/asia.202400824

Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy

Ubaldina Galli, Marianna Moro, Federica Carolina Balestrero, Giorgia Colombo, Marco Koten, Benedetta Roncaglio, Armando A. Genazzani, Silvio Aprile, Alberto Massarotti, Giuseppe Orsomando, Tracey Pirali and Ambra A. Grolla

J. Med. Chem., 2026, 69, 5259
DOI: 10.1021/acs.jmedchem.5c01827

Cardiomyocyte-specific NHE1 overexpression confers protection against myocardial infarction during hyperglycemia

Kai Jiang, Fanghua Su, Ruhua Deng, Yue Xu, Anqi Qin, Xun Yuan, Dongmei Xing, Yang Chen, Dandan Wang, Lan Shen, John Hwa, Lei Hou and Yaozu Xiang

Cardiovasc Diabetol, 2025, 24
DOI: 10.1186/s12933-025-02743-3

Targeted protein degradation: species, diseases and efficient utilization

Tian Yue, Jian He and Jun Hou

J Transl Med, 2025, 24
DOI: 10.1186/s12967-025-07610-z

PSMA-Targeting Chimeras for Cell-Type-Specific Degradation of Surface Immune Checkpoint Protein PD-L1

Yuqing Luo, Xiaoxiao Gong, Keren Peng, Yanqing Yang, Meng Chen, Yu Guo, Kang Chen, Jinming Gao, Xing Su, Jinxin Che, Xiaowu Dong, Jiang-Jiang Tang, Xiaolei Zhang, Peng Teng and Ruhong Zhou

JACS Au, 2026, 6, 279
DOI: 10.1021/jacsau.5c01216

Securing LYTAC with Logic‐Identification System for Cancer Cell‐Selective Membrane Protein Degradation

Yanyun Fang, Yue Zhang, Shiyi Bi, Bo Peng, Caixia Wang, Huangxian Ju and Ying Liu

Small, 2024, 20
DOI: 10.1002/smll.202310039

Lysosome-centered nanomedicine for cancer therapy: mechanisms, materials, and modalities

Rongwei Xu, Nina Li, Xu Chen, Meiyan Zou, Weiyao Feng, Zihao Zhou, Zhiyu Guo, Xinyuan Zhao, Shuguang Liu and Li Cui

J Nanobiotechnol, 2026
DOI: 10.1186/s12951-026-04438-7

Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs

Yanping Zeng, Jian Xiao, Yuanxin Xu, Fan Wei, Lina Tian, Yinglei Gao, Yi Chen and Youhong Hu

J. Med. Chem., 2023, 66, 12877
DOI: 10.1021/acs.jmedchem.3c00828

Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway

Xiaofeng Liao, Geng Qin, Zhenqi Liu, Jinsong Ren and Xiaogang Qu

Small, 2024, 20
DOI: 10.1002/smll.202306760

Discovery of Novel PDEδ Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC)

Jingying Bao, Zhenqian Chen, Yu Li, Long Chen, Wei Wang, Chunquan Sheng and Guoqiang Dong

ACS Med. Chem. Lett., 2024, 15, 29
DOI: 10.1021/acsmedchemlett.3c00161

The application of PROTAC in HDAC

Shaoting Chen, Yuxiang Zheng, Benji Liang, Yudong Yin, Jian Yao, Quande Wang, Yanghan Liu and Nouri Neamati

European Journal of Medicinal Chemistry, 2023, 260, 115746
DOI: 10.1016/j.ejmech.2023.115746

Perspectives of autophagy-tethering compounds (ATTECs) in drug discovery

Yu Ding, Dong Xing, Yiyan Fei, Shouqing Luo and Boxun Lu

Medicine Plus, 2024, 1, 100004
DOI: 10.1016/j.medp.2023.100004

Epigenetics-targeted drugs: current paradigms and future challenges

Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, Renhao Guo, Peng Bai, Shuang Liu, Tingting Li, Yutao Jiang, Shuang Wei, Zhijing Na, Xue Xiao and Da Li

Sig Transduct Target Ther, 2024, 9
DOI: 10.1038/s41392-024-02039-0

Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics

Wutong Zhao, Yongbin Jiang, Xiufen Li and Hai Wang

WIREs Nanomed Nanobiotechnol, 2024, 16
DOI: 10.1002/wnan.2020

Supramolecular Host–Guest Assemblies for Tunable and Modular Lysosome‐Targeting Protein Degradation

Xuetao Chen, Tingting Wu, Yali Chen, Huidan Wu, Wenjing Kang, Nan Wang, Qidong You, Xiaoke Guo and Zhengyu Jiang

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202506618

Lysosome-Targeting Chimeras: Design, Mechanisms, and Degradation of “Rogue” Proteins

Muneeb Ur Rehman, Xinxi Wu, Qun Chen, Ziwei Liu and Sihui Long

Bioorganic Chemistry, 2025, 167, 109249
DOI: 10.1016/j.bioorg.2025.109249

Multi-omics dissection of Parkinson’s patients in subgroups associated with motor and cognitive severity

Efi Athieniti, Sotiroula Afxenti, George Minadakis and George M. Spyrou

Neurobiology of Disease, 2026, 220, 107288
DOI: 10.1016/j.nbd.2026.107288

Inhibitors to degraders: Changing paradigm in drug discovery

V. Haridas, Souvik Dutta, Akshay Munjal and Shailja Singh

iScience, 2024, 27, 109574
DOI: 10.1016/j.isci.2024.109574

Autophagy-tethering compounds (ATTECs) as an emerging and potentially transformative drug discovery approach

Zhi Ying Dorothy Wong, Xinyi Kang, Yaoyao Shi, Rui Fan, Chenchen Zhang, Delin Min, Nannan Sun, Youzhen Ma and Mei-Lin Tang

European Journal of Medicinal Chemistry, 2026, 305, 118585
DOI: 10.1016/j.ejmech.2026.118585

Induced-proximity therapeutics for targeted protein and RNA degradation: An organic chemistry Perspective-A review

Mohammad Rizehbandi, Ehsan Dadfar, Mahyar Rezaei Nami, Mahdi Rezaei Nami and Mehran Rezaei Nami

Current Research in Structural Biology, 2026, 11, 100181
DOI: 10.1016/j.crstbi.2026.100181

Recent advance in the targeted protein degradation technology for overcoming acute leukemia

Xin Jin, Zhonghua Shi, Zhuo Liang, Jia Chen, Chenxi Wang, Yongxin Lou, Xiaoran Cao, Lei Zhu, Yihuan Zhao, Changkuo Zhao, Xianheng Wang and Qiang Huang

European Journal of Medicinal Chemistry Reports, 2026, 17, 100331
DOI: 10.1016/j.ejmcr.2026.100331

Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation

Qi Xu, Dan Liu, Ling‐Qiang Zhu, Ying Su and He‐Zhou Huang

Alzheimer's & Dementia, 2025, 21
DOI: 10.1002/alz.14498

From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation

Siqi Wang, Fuchu He, Chunyan Tian and Aihua Sun

Pharmaceuticals, 2024, 17, 100
DOI: 10.3390/ph17010100

Targeting EGFR degradation by autophagosome degraders

ZhongFeng Zhu, Jiaying Li, Shujun Shen, Hawaa Al-furas, Shengrong Li, Yichen Tong, Yi Li, Yucheng Zeng, Qianyi Feng, Kaiyue Chen, Nan Ma, Fengtao Zhou, Zhang Zhang, Zhengqiu Li, Jiyan Pang, Ke Ding and Fang Xu

European Journal of Medicinal Chemistry, 2024, 270, 116345
DOI: 10.1016/j.ejmech.2024.116345

Autophagy and Mycobacterium Tuberculosis: the role of autophagy in antimicrobial immunity and therapy

Hong Lei, Junya Lan, Yanan Chen, Jie Liu, Yushan Yao, Nannan Zhou, Xiudong Ding and Ying Jiang

Front. Cell. Infect. Microbiol., 2026, 16
DOI: 10.3389/fcimb.2026.1748677

The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders

Pengyun Li, Bingkun Li, Ning Yang, Tingting Xu and Zhibing Zheng

Expert Opinion on Therapeutic Patents, 2023, 33, 477
DOI: 10.1080/13543776.2023.2262176

Glucose Transporter-Targeting Chimeras Enabling Tumor-Selective Degradation of Secreted and Membrane Proteins

Chengyu Yun, Na Li, Yishu Zhang, Tong Fang, Jing Ma, Zhenting Zheng, Subing Zhou and Xiaoqing Cai

ACS Chem. Biol., 2024, 19, 2254
DOI: 10.1021/acschembio.4c00584

Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

Haoran Lu, Zixiao Yang, Muzaffar Kayumov, Yazhen Wang, Fanhao Tang, Xianxin Wang, Tianyue Xia, Ting Lei, Fan Tong and Huile Gao

ACS Nano, 2026, 20, 13417
DOI: 10.1021/acsnano.6c04420

Recent advances in developing targeted protein degraders

Binbin Cheng, Hongqiao Li, Xiaopeng Peng, Jianjun Chen, Chuxiao Shao and Zhihua Kong

European Journal of Medicinal Chemistry, 2025, 284, 117212
DOI: 10.1016/j.ejmech.2024.117212

Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity

Bingjie Hao, Shumeng Lin, Haipeng Liu, Junfang Xu, Li Chen, Tiansheng Zheng, Wen Zhang, Yifang Dang, Russel J. Reiter, Chaoqun Li, Hong Zhai, Qing Xia and Lihong Fan

Autophagy, 2025, 21, 917
DOI: 10.1080/15548627.2024.2439657

Recent advances in targeted degradation in the RAS pathway

Zhiming Ge, Zisheng Fan, Wei He, Guizhen Zhou, Yidi Zhou, Mingyue Zheng and Sulin Zhang

Future Medicinal Chemistry, 2025, 17, 693
DOI: 10.1080/17568919.2025.2476387

The design, synthesis and bioactivity evaluation of novel androgen receptor degraders based on hydrophobic tagging

Ying Sun, Huating Wang, Yaru Li, Zhaoxiang Li, Zhihui Mao, Mengyao Zhang, Yixian Shao, Jiaqi Ye, Dan Li and Lihong Shan

Bioorganic Chemistry, 2024, 146, 107309
DOI: 10.1016/j.bioorg.2024.107309

Strategies for Precise Modulation of Protein Degradation

Shipeng He, Guoqiang Dong and Chunquan Sheng

Acc. Chem. Res., 2025, 58, 1236
DOI: 10.1021/acs.accounts.5c00003

Advances and challenges of targeted protein degradation in ophthalmology: Future directions and therapeutic potential

Ke Feng, Mingyan Wei, Panqin Ma, Jiaoyue Hu, Caihong Huang, Yi Han and Zuguo Liu

Materials & Design, 2025, 259, 114767
DOI: 10.1016/j.matdes.2025.114767

Systematic evolution of functional oligonucleotides for targeted protein degradation

Huang Su, Yifan Chen, Xuyang Zhao, Zengyi Lu, Tongxuan Wei, Qinguo Liu, Xiyang Liu, Qinhao Zhang, Siqi Bian, Qianwei Qiu, Panzhu Yao, Wenlang Liu, Zheng Zheng, Da Xu and Liqin Zhang

Chem, 2025, 11, 102408
DOI: 10.1016/j.chempr.2024.102408